Reply to “Exploring the long-term effects of biologic initiation in severe asthma: Insights from the International Severe Asthma Registry”

W. Chen, L. Bjermer, M.E. Wechsler, D.B. Price

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)536-539
Number of pages4
JournalJournal of Allergy and Clinical Immunology: In Practice
Issue number2
Publication statusPublished - 2024

Subject classification (UKÄ)

  • Respiratory Medicine and Allergy

Free keywords

  • biological product
  • corticosteroid
  • mepolizumab
  • age
  • biological therapy
  • body mass
  • disease exacerbation
  • disease registry
  • drug efficacy
  • drug response
  • drug use
  • human
  • Letter
  • people by smoking status
  • personalized medicine
  • phenotype
  • prognosis
  • severe asthma
  • sex
  • sinonasal polyp

Cite this